The new bronchodilator for COPD (not asthma) was reviewed by The Medical Letter® in the April 30, 2012 issue.  I’ll include the news release from Novartis from last year. Indacaterol (Arcapta Neohaler) news release  Once a medication has been on the market for one year, side effects usually show up and clinical effectiveness is more realistic.  Indacaterol (Arcapta Neohaler) did well:…